Tag Archives: ibm
Artificial intelligence has received its fair share of hype recently. However, it’s hype that’s well-founded: IDC predicts worldwide spend on AI and cognitive computing will culminate to a whopping $46 billion (with a “b”) by 2020, and all the tech giants are jumping on board faster than you can say “ROI.” But what is AI, exactly?
According to Hilary Mason, AI today is being misused as a sort of catch-all term to basically describe “any system that uses data to do anything.” But it’s so much more than that. A truly artificially intelligent system is one that learns on its own, one that’s capable of crunching copious amounts of data in order to create associations and intelligently mimic actual human behavior.
It’s what powers the technology anticipating our next online purchase (Amazon), or the virtual assistant that deciphers our voice commands with incredible accuracy (Siri), or even the hipster-friendly recommendation engine that helps you discover new music before your friends do (Pandora). But AI is moving past these consumer-pleasing “nice-to-haves” and getting down to serious business: saving our butts.
Much in the same way robotics entered manufacturing, AI is making its mark in healthcare by automating mundane, repetitive tasks. This is especially true in the case of detecting cancer. By leveraging the power of deep learning, algorithms can now be trained to distinguish between sets of pixels in an image that represents cancer versus sets that don’t—not unlike how Facebook’s image recognition software tags pictures of our friends without us having to type in their names first. This software can then go ahead and scour millions of medical images (MRIs, CT scans, etc.) in a single day to detect anomalies on a scope that humans just aren’t capable of. That’s huge.
As if that wasn’t enough, these algorithms are constantly learning and evolving, getting better at making these associations with each new data set that gets fed to them. Radiology, dermatology, and pathology will experience a giant upheaval as tech giants and startups alike jump in to bring these deep learning algorithms to a hospital near you.
In fact, some already are: the FDA recently gave their seal of approval for an AI-powered medical imaging platform that helps doctors analyze and diagnose heart anomalies. This is the first time the FDA has approved a machine learning application for use in a clinical setting.
But how efficient is AI compared to humans, really? Well, aside from the obvious fact that software programs don’t get bored or distracted or have to check Facebook every twenty minutes, AI is exponentially better than us at analyzing data.
Take, for example, IBM’s Watson. Watson analyzed genomic data from both tumor cells and healthy cells and was ultimately able to glean actionable insights in a mere 10 minutes. Compare that to the 160 hours it would have taken a human to analyze that same data. Diagnoses aside, AI is also being leveraged in pharmaceuticals to aid in the very time-consuming grunt work of discovering new drugs, and all the big players are getting involved.
But AI is far from being just a behind-the-scenes player. Gartner recently predicted that by 2025, 50 percent of the population will rely on AI-powered “virtual personal health assistants” for their routine primary care needs. What this means is that consumer-facing voice and chat-operated “assistants” (think Siri or Cortana) would, in effect, serve as a central hub of interaction for all our connected health devices and the algorithms crunching all our real-time biometric data. These assistants would keep us apprised of our current state of well-being, acting as a sort of digital facilitator for our personal health objectives and an always-on health alert system that would notify us when we actually need to see a physician.
Slowly, and thanks to the tsunami of data and advancements in self-learning algorithms, healthcare is transitioning from a reactive model to more of a preventative model—and it’s completely upending the way care is delivered. Whether Elon Musk’s dystopian outlook on AI holds any weight or not is yet to be determined. But one thing’s certain: for the time being, artificial intelligence is saving our lives.
Image Credit: Jolygon / Shutterstock.com Continue reading
The brain has long inspired the design of computers and their software. Now Intel has become the latest tech company to decide that mimicking the brain’s hardware could be the next stage in the evolution of computing.
On Monday the company unveiled an experimental “neuromorphic” chip called Loihi. Neuromorphic chips are microprocessors whose architecture is configured to mimic the biological brain’s network of neurons and the connections between them called synapses.
While neural networks—the in vogue approach to artificial intelligence and machine learning—are also inspired by the brain and use layers of virtual neurons, they are still implemented on conventional silicon hardware such as CPUs and GPUs.
The main benefit of mimicking the architecture of the brain on a physical chip, say neuromorphic computing’s proponents, is energy efficiency—the human brain runs on roughly 20 watts. The “neurons” in neuromorphic chips carry out the role of both processor and memory which removes the need to shuttle data back and forth between separate units, which is how traditional chips work. Each neuron also only needs to be powered while it’s firing.
At present, most machine learning is done in data centers due to the massive energy and computing requirements. Creating chips that capture some of nature’s efficiency could allow AI to be run directly on devices like smartphones, cars, and robots.
This is exactly the kind of application Michael Mayberry, managing director of Intel’s research arm, touts in a blog post announcing Loihi. He talks about CCTV cameras that can run image recognition to identify missing persons or traffic lights that can track traffic flow to optimize timing and keep vehicles moving.
There’s still a long way to go before that happens though. According to Wired, so far Intel has only been working with prototypes, and the first full-size version of the chip won’t be built until November.
Once complete, it will feature 130,000 neurons and 130 million synaptic connections split between 128 computing cores. The device will be 1,000 times more energy-efficient than standard approaches, according to Mayberry, but more impressive are claims the chip will be capable of continuous learning.
Intel’s newly launched self-learning neuromorphic chip.
Normally deep learning works by training a neural network on giant datasets to create a model that can then be applied to new data. The Loihi chip will combine training and inference on the same chip, which will allow it to learn on the fly, constantly updating its models and adapting to changing circumstances without having to be deliberately re-trained.
A select group of universities and research institutions will be the first to get their hands on the new chip in the first half of 2018, but Mayberry said it could be years before it’s commercially available. Whether commercialization happens at all may largely depend on whether early adopters can get the hardware to solve any practically useful problems.
So far neuromorphic computing has struggled to gain traction outside the research community. IBM released a neuromorphic chip called TrueNorth in 2014, but the device has yet to showcase any commercially useful applications.
Lee Gomes summarizes the hurdles facing neuromorphic computing excellently in IEEE Spectrum. One is that deep learning can run on very simple, low-precision hardware that can be optimized to use very little power, which suggests complicated new architectures may struggle to find purchase.
It’s also not easy to transfer deep learning approaches developed on conventional chips over to neuromorphic hardware, and even Intel Labs chief scientist Narayan Srinivasa admitted to Forbes Loihi wouldn’t work well with some deep learning models.
Finally, there’s considerable competition in the quest to develop new computer architectures specialized for machine learning. GPU vendors Nvidia and AMD have pivoted to take advantage of this newfound market and companies like Google and Microsoft are developing their own in-house solutions.
Intel, for its part, isn’t putting all its eggs in one basket. Last year it bought two companies building chips for specialized machine learning—Movidius and Nervana—and this was followed up with the $15 billion purchase of self-driving car chip- and camera-maker Mobileye.
And while the jury is still out on neuromorphic computing, it makes sense for a company eager to position itself as the AI chipmaker of the future to have its fingers in as many pies as possible. There are a growing number of voices suggesting that despite its undoubted power, deep learning alone will not allow us to imbue machines with the kind of adaptable, general intelligence humans possess.
What new approaches will get us there are hard to predict, but it’s entirely possible they will only work on hardware that closely mimics the one device we already know is capable of supporting this kind of intelligence—the human brain.
Image Credit: Intel Continue reading
We’re no stranger to robotics in the medical field. Robot-assisted surgery is becoming more and more common. Many training programs are starting to include robotic and virtual reality scenarios to provide hands-on training for students without putting patients at risk.
With all of these advances in medical robotics, three niches stand out above the rest: surgery, medical imaging, and drug discovery. How have robotics already begun to exert their influence on these practices, and how will they change them for good?
Robot-assisted surgery was first documented in 1985, when it was used for a neurosurgical biopsy. This led to the use of robotics in a number of similar surgeries, both laparoscopic and traditional operations. The FDA didn’t approve robotic surgery tools until 2000, when the da Vinci Surgery system hit the market.
The robot-assisted surgery market is expected to grow steadily into 2023 and potentially beyond. The only thing that might stand in the way of this growth is the cost of the equipment. The initial investment may prevent small practices from purchasing the necessary devices.
The key to successful medical imaging isn’t the equipment itself. It’s being able to interpret the information in the images. Medical images are some of the most information-dense pieces of data in the medical field and can reveal so much more than a basic visual inspection can.
Robotics and, more specifically, artificial intelligence programs like IBM Watson can help interpret these images more efficiently and accurately. By allowing an AI or basic machine learning program to study the medical images, researchers can find patterns and make more accurate diagnoses than ever before.
Drug discovery is a long and often tedious process that includes years of testing and assessment. Artificial intelligence, machine learning and predictive algorithms could help speed up this system.
Imagine if researchers could input the kind of medicine they’re trying to make and the kind of symptoms they’re trying to treat into a computer and let it do the rest. With robotics, that may someday be possible.
This isn’t a perfect solution yet—these systems require massive amounts of data before they can start making decisions or predictions. By feeding data into the cloud where these programs can access it, researchers can take the first steps towards setting up a functional database.
Another benefit of these AI programs is that they might see connections humans would never have thought of. People can make those leaps, but the chances are much lower, and it takes much longer if it happens at all. Simply put, we’re not capable of processing the sheer amount of data that computers can process.
This isn’t a field where we’re worrying about robots stealing jobs.
Quite the opposite, in fact—we want robots to become commonly-used tools that can help improve patient care and surgical outcomes.
A human surgeon might have intuition, but they’ll never have the steadiness that a pair of robotic hands can provide or the data-processing capabilities of a machine learning algorithm. If we let them, these tools could change the way we look at medicine.
Image Credit: Intuitive Surgical Continue reading